Security Television Network
ASTMH 2015
ASTMH 2015_ 1276 Long term efficacy, safety, reactogenicity, and immunogenicity of phase IIA,
About this video
ASTMH 2015_ 1276 Long term efficacy, safety, reactogenicity, and immunogenicity of phase IIA,
Attribution: Source: DVIDS Hub — U.S. Department of Defense public-affairs media
The interactive STN application appears here when JavaScript is available. Published facts and source links above remain readable without JavaScript.